Correlation Between Exelixis and Ultragenyx
Can any of the company-specific risk be diversified away by investing in both Exelixis and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Ultragenyx, you can compare the effects of market volatilities on Exelixis and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Ultragenyx.
Diversification Opportunities for Exelixis and Ultragenyx
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Exelixis and Ultragenyx is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Exelixis i.e., Exelixis and Ultragenyx go up and down completely randomly.
Pair Corralation between Exelixis and Ultragenyx
Given the investment horizon of 90 days Exelixis is expected to generate 0.98 times more return on investment than Ultragenyx. However, Exelixis is 1.02 times less risky than Ultragenyx. It trades about 0.08 of its potential returns per unit of risk. Ultragenyx is currently generating about -0.06 per unit of risk. If you would invest 3,330 in Exelixis on December 31, 2024 and sell it today you would earn a total of 340.00 from holding Exelixis or generate 10.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Exelixis vs. Ultragenyx
Performance |
Timeline |
Exelixis |
Ultragenyx |
Exelixis and Ultragenyx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Exelixis and Ultragenyx
The main advantage of trading using opposite Exelixis and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stocks Directory Find actively traded stocks across global markets |